Search

everythinglearnresearchcommunity

for

Search:↓

The correction states that the label change for Finasteride was in 2012, leading to more reports of side effects from non-healthcare people.

Patient-reported hair improvements align with actual hair density changes, not hair width.

The saw palmetto extract effectively inhibits an enzyme linked to prostate issues, showing promise for prostate health.

Wildfire air pollution is linked to more online searches and clinic visits for psoriasis in adults after a delay.

The peer review highlighted the need for clearer data handling, questioned the study's validity, and recognized improvements from the original version.

The conclusion is that finasteride is linked to an increased risk of suicidal thoughts and a higher risk of completed suicide when used for hair loss.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Placebo effects in alopecia treatments are likely due to study design, not real improvement.

Scalp coverage scoring accurately measures hair loss and treatment effectiveness.

PSI-MS quickly and accurately measures finasteride in tablets, helping with quality control.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Finasteride is linked to sexual dysfunction, especially in younger users treating hair loss.

Parents often claim to use more home safety measures than they actually do.

Toupees improved perceived attractiveness, especially by older people, but had little effect on perceived self-assurance and health.

Reviewers suggested the study on finding new drug uses through social media side-effects needs better methods and clearer limitations.

Finasteride's benefits outweigh its risks.

Low quality of life and high HSS-29 scores increase risk of losing patients during treatment.

The SBN system effectively assesses alopecia areata severity and predicts its course.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

The test and reference finasteride tablets are bioequivalent.

The HAIR-Q is a reliable tool for assessing patient satisfaction with hair loss treatments.

More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

New method measures skin cell turnover quickly and effectively, showing turnover slows with age and responds more to treatments in older skin.

Keyword advertising is effective for reaching and targeting consumers.

The Dermatology Life Quality Index is reliable and consistent but needs more diverse participant studies.

Pharmacy-sold shampoos tend to have fewer allergens compared to those sold in other stores.

The modified wash test is better than TrichoScan® for diagnosing hair loss.

Patients often overestimate their skin type, affecting sun protection and treatment plans.

Some prostate cancers have gene changes that may affect treatment with certain drugs.